Indications And Dose
Bronchospasm in chronic obstructive pulmonary disease ▶BY INHALATION OF NEBULISED SOLUTION ▶Adult: 0.5/2.5 mg 3–4 times a day
PDF page 283
Loading InternPractice…
Drug reference
Bronchospasm in chronic obstructive pulmonary disease ▶BY INHALATION OF NEBULISED SOLUTION ▶Adult: 0.5/2.5 mg 3–4 times a day
PDF page 283
A mixture of ipratropium bromide and salbutamol (as sulphate); the proportions are expressed in the form x/y where x and y are the strengths in milligrams of ipratropium and salbutamol respectively.
PDF page 283
→Appendix 1: beta2 agonists. ipratropium
PDF page 283
There can be variation in the licensing of different medicines containing the same drug. Nebuliser liquid ▶Combivent (Boehringer Ingelheim Ltd) Ipratropium bromide 200 microgram per 1 ml, Salbutamol (as Salbutamol sulfate) 1 mg per 1 ml Combivent nebuliser liquid 2.5ml Respiratory system UDVs | 60 unit dose P £24.10 DT = £24.10 ▶Ipramol (Teva UK Ltd) Ipratropium bromide 200 microgram per 1 ml, Salbutamol (as Salbutamol sulfate) 1 mg per 1 ml Ipramol nebuliser solution 2.5ml Steri-Neb unit dose vials | 60 unit dose P £23.83 DT = £24.10 eiiii F 259
PDF page 284
0.5/2.5 mg 3–4 times a day
First-line fragment. Read the complete Indications and Dose section above.
PDF page 283